Remote monitoring technologies in Alzheimer's disease: design of the RADAR-AD study.
Marijn MuurlingCasper de BoerRouba KozakDorota ReligaIvan KoychevHerman VerheijVera J M NiesAlexander DuyndamMeemansa SoodHolger FröhlichKristin HannesdottirGul ErdemliFederica LuciveroClaire LancasterChris HindsThanos G StravopoulosSpiros NikolopoulosIoannis KompatsiarisNikolay V ManyakovAndrew P OwensVaibhav A NarayanDag AarslandPieter Jelle Vissernull nullPublished in: Alzheimer's research & therapy (2021)
Our study is well placed to evaluate the clinical utility of RMT assessments. Leveraging modern-day technology may deliver new and improved methods for accurately monitoring functional decline in all stages of AD. It is greatly anticipated that these methods could lead to objective and real-life functional endpoints with increased sensitivity to pharmacological agent signal detection.